Stephan C. Urban
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications
When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.
Journal: Journal of hepatology
Published: May 25, 2026
Absence of Detectable Anti-HDV Antibodies Among HBsAg-Positive Blood Donors, HIV-Infected Individuals and Patients With Chronic Hepatitis B in Sao Paulo, Brazil: Evaluation Using a Rapid Lateral Flow Assay.
Journal: Journal of viral hepatitis
Published: April 15, 2026
Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts.
Journal: Nature reviews. Gastroenterology & hepatology
Published: March 12, 2026
A new hepatitis delta virus hotspot in Ethiopia: A multicenter study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 03, 2026
Correction: RBM39 shapes innate immunity by controlling expression of key factors of the interferon response.
Journal: Frontiers in immunology
Published: January 06, 2026
CDK8 and CDK19 Mediator kinases are required for hepatitis delta virus replication.
Journal: Hepatology (Baltimore, Md.)
Published: October 12, 2025
Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment.
Journal: Journal of virology
Published: September 18, 2025
Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus.
Journal: Scientific reports
Published: July 03, 2025
Identification of NTCP animal orthologs supporting hepatitis B virus binding and infection.
Journal: Journal of virology
Published: March 05, 2025
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response.
Journal: Frontiers in immunology
Published: January 28, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis Delta.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 28, 2024
Last Updated: 09/26/2026